Timothy M. Lestingi

Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea.

E Gupta, Timothy M. Lestingi, Rosemarie Mick et al. · PubMed · 1994 · 506 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients.

E Gupta, Rosemarie Mick, Xiaolin Wang et al. · Journal of Clinical Oncology · 1997 · 181 citations

Medicine, Pharmacokinetics, Pharmacology +17

Combination of Chemotherapy With Interleukin-2 and Interferon Alfa for the Treatment of Metastatic Melanoma

Jon Richards, Danielle Gale, Nilesh Mehta et al. · Journal of Clinical Oncology · 1999 · 102 citations

Medicine, Oncology, Pharmacology +17

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

A phase II study evaluating the toxicity and efficacy of single-agent temsirolimus in chemotherapy-naïve castration-resistant prostate cancer

Kimberly Kruczek, Megan Ratterman, Kathy Tolzien et al. · British Journal of Cancer · 2013 · 56 citations · Full text

Medicine, Oncology, Pharmacology +17